[go: up one dir, main page]

FI64942C - Analogifoerfarande foer framstaellning av terapeutiskt anvaendbar 6'-desoxo-9,10-dihydro-beta-ergocryptin och salter daerav - Google Patents

Analogifoerfarande foer framstaellning av terapeutiskt anvaendbar 6'-desoxo-9,10-dihydro-beta-ergocryptin och salter daerav Download PDF

Info

Publication number
FI64942C
FI64942C FI772557A FI772557A FI64942C FI 64942 C FI64942 C FI 64942C FI 772557 A FI772557 A FI 772557A FI 772557 A FI772557 A FI 772557A FI 64942 C FI64942 C FI 64942C
Authority
FI
Finland
Prior art keywords
compound
formula
dihydro
acid
therapeutic
Prior art date
Application number
FI772557A
Other languages
English (en)
Finnish (fi)
Other versions
FI772557A (fi
FI64942B (fi
Inventor
Peter Stuetz
Paul Stadler
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1128776A external-priority patent/CH623592A5/de
Priority claimed from CH1128676A external-priority patent/CH623591A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI772557A publication Critical patent/FI772557A/fi
Publication of FI64942B publication Critical patent/FI64942B/fi
Application granted granted Critical
Publication of FI64942C publication Critical patent/FI64942C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI772557A 1976-09-06 1977-08-29 Analogifoerfarande foer framstaellning av terapeutiskt anvaendbar 6'-desoxo-9,10-dihydro-beta-ergocryptin och salter daerav FI64942C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1128776 1976-09-06
CH1128676 1976-09-06
CH1128776A CH623592A5 (en) 1976-09-06 1976-09-06 Process for the preparation of ergopeptide alkaloid derivatives
CH1128676A CH623591A5 (en) 1976-09-06 1976-09-06 Process for the preparation of ergopeptide alkaloid derivatives

Publications (3)

Publication Number Publication Date
FI772557A FI772557A (fi) 1978-03-07
FI64942B FI64942B (fi) 1983-10-31
FI64942C true FI64942C (fi) 1984-02-10

Family

ID=25708069

Family Applications (1)

Application Number Title Priority Date Filing Date
FI772557A FI64942C (fi) 1976-09-06 1977-08-29 Analogifoerfarande foer framstaellning av terapeutiskt anvaendbar 6'-desoxo-9,10-dihydro-beta-ergocryptin och salter daerav

Country Status (15)

Country Link
JP (1) JPS5331698A (pt)
AU (1) AU512027B2 (pt)
CA (1) CA1105007A (pt)
DE (1) DE2738730A1 (pt)
DK (1) DK147390C (pt)
ES (1) ES462080A1 (pt)
FI (1) FI64942C (pt)
FR (1) FR2363571A1 (pt)
GB (2) GB1590150A (pt)
IE (1) IE46152B1 (pt)
IL (1) IL52896A (pt)
NL (1) NL7709683A (pt)
NZ (1) NZ185098A (pt)
PT (1) PT67003B (pt)
SE (1) SE435839B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012177962A1 (en) * 2011-06-23 2012-12-27 Map Pharmaceuticals, Inc. Novel fluoroergoline analogs

Also Published As

Publication number Publication date
IL52896A0 (en) 1977-11-30
IE46152L (en) 1978-03-06
NZ185098A (en) 1980-04-28
DK147390C (da) 1985-02-04
PT67003B (en) 1979-05-14
IE46152B1 (en) 1983-03-09
NL7709683A (nl) 1978-03-08
FR2363571B1 (pt) 1980-04-18
GB1590150A (en) 1981-05-28
FI772557A (fi) 1978-03-07
ES462080A1 (es) 1978-12-01
GB1590149A (en) 1981-05-28
DK382777A (da) 1978-03-07
AU512027B2 (en) 1980-09-18
DE2738730A1 (de) 1978-03-16
PT67003A (en) 1977-10-01
CA1105007A (en) 1981-07-14
IL52896A (en) 1980-07-31
FI64942B (fi) 1983-10-31
SE7709645L (sv) 1978-03-07
SE435839B (sv) 1984-10-22
JPS5331698A (en) 1978-03-25
FR2363571A1 (fr) 1978-03-31
AU2857277A (en) 1979-03-15
DK147390B (da) 1984-07-16

Similar Documents

Publication Publication Date Title
JPH0229080B2 (pt)
KR100312539B1 (ko) 피페라진유도체
SU1308196A3 (ru) Способ получени 5,11-дигидро-11- @ (1-метил-4-пиперидинил)-амино @ -карбонил @ -6 @ -дибенз ( @ , @ )азепин-6-она или его солей
JPS62283960A (ja) ジ−およびテトラヒドロイソキノリン誘導体およびその製造方法
FI64942C (fi) Analogifoerfarande foer framstaellning av terapeutiskt anvaendbar 6'-desoxo-9,10-dihydro-beta-ergocryptin och salter daerav
PT874849E (pt) Derivados octa-hidro-pirrolo¬1,2-a|pirazina 2,7-substituidos
FR2585709A1 (fr) Nouveaux derives peptidiques a structure lactonique ou cycloamidique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US4124712A (en) Ergot peptide alkaloid derivatives
FR2643076A1 (fr) Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
FR2652352A1 (fr) Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique.
JPS5813542B2 (ja) シンキエルゴリンユウドウタイノ セイホウ
US3901891A (en) 13-bromolysergic acid compounds
JP2690749B2 (ja) ベンズイミダゾール誘導体、その製造方法およびその医薬への応用
FI78101C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla n-(2-metoxietyl)-noroximorfoner.
CN113214238B (zh) 一类具有酰化哌嗪结构的吲哚恶二唑衍生物的制备和用途
EP0684257B1 (fr) Pseudopeptides dérivés de neurokinines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
FI68841C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara erotpeptidalkaloidderivat
CA2109774A1 (fr) Derives du pyrrole, leur preparation et leur application therapeutique
US4287211A (en) Derivatives of phenylethylamines, processes for their preparation and related pharmaceutical compositions
BE897208A (fr) Composes de carbostyryle
US3404156A (en) Imidazolin-2-yl-alkyl-substituted indoles
FI71736B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara erolinderivat och deras syraadditionssalter
US4547500A (en) Ergot peptide derivatives, their preparation and pharmaceutical compositions containing them
JP3157171B2 (ja) シネルギスチンの製造方法
EP0663903B1 (fr) Derives de dihydro-1,2 oxo-2 amino-3 quinoxalines, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANDOZ AG